Real-life effectiveness of upadacitinib for early and sustained pain relief in radiographic axial spondyloarthritis (UPSTAND)
OBSERVATIONAL STUDY WITH MEDICATION
Clinical trial information
- Promoter: ABBVIE SPAIN SLU
- Execution start: 16/03/2023
- End of execution: 30/06/2025
- PI: ENRIQUE RAYA ALVAREZ
